Skip to main content

Research Repository

Advanced Search

Endocrinology of transgender medicine

T’Sjoen, Guy; Arcelus, Jon; Gooren, Louis; Klink, Daniel T.; Tangpricha, Vin

Authors

Guy T’Sjoen

JON ARCELUS ALONSO Jon.Arcelus@nottingham.ac.uk
Clinical Professor in Mental Health & Transgender Health

Louis Gooren

Daniel T. Klink

Vin Tangpricha



Abstract

Gender affirming treatment for transgender people requires a multidisciplinary approach in which endocrinologists play a crucial role. The aim of this paper is to review recent data on hormonal treatment of this population and its effect on physical, psychological and mental health. The Endocrine Society guidelines for transgender women include estrogens in combination with androgen lowering medications. Feminizing treatment with estrogens and anti-androgens has desired physical changes, such as enhanced breast growth, reduction of facial and body hair growth and fat redistribution in a female pattern. Possible side effects should be discussed with patients, particularly those at risk of venous thromboembolism. The Endocrine Society guidelines for transgender men include testosterone therapy for virilization with deepening of the voice, cessation of menses plus increase of muscle mass, facial and body hair. Due to the lack of evidence, treatment for gender non-binary people should be individualized. Young people may receive pubertal suspension, consisting of gonadotrophin-releasing hormone analogs, later followed by sex steroids. Options for fertility preservation should be discussed before any hormonal intervention. Morbidity and cardiovascular risk with cross-sex hormones is unchanged among transgender men and unclear among transgender women. Sex steroid-related malignancies can occur, but are rare. Mental health problems such as depression and anxiety have been found to reduce considerably following hormonal treatment. Future studies should aim to explore the long-term outcome of hormonal treatment in transgender people and provide evidence as to effect of gender affirming treatment in the non-binary population.

Citation

T’Sjoen, G., Arcelus, J., Gooren, L., Klink, D. T., & Tangpricha, V. (2019). Endocrinology of transgender medicine. Endocrine Reviews, 40(1), 97–117. doi:10.1210/er.2018-00011

Journal Article Type Article
Acceptance Date Jun 21, 2018
Online Publication Date Oct 10, 2018
Publication Date 2019-02
Deposit Date Jun 22, 2018
Publicly Available Date Oct 11, 2019
Journal Endocrine Reviews
Print ISSN 0163-769X
Electronic ISSN 0163-769X
Publisher Oxford University Press
Peer Reviewed Peer Reviewed
Volume 40
Issue 1
Pages 97–117
DOI https://doi.org/10.1210/er.2018-00011
Keywords transgender, gender identity, testosterone, estrogen, anti-androgen, puberty
Public URL http://eprints.nottingham.ac.uk/id/eprint/52568
Publisher URL https://academic.oup.com/edrv/advance-article/doi/10.1210/er.2018-00011/5123979
Copyright Statement Copyright information regarding this work can be found at the following address: http://eprints.nottingh.../end_user_agreement.pdf

Files

Endocrinology of Transgender Medicine.R1Clean.pdf (425 Kb)
PDF

Copyright Statement
Copyright information regarding this work can be found at the following address: http://eprints.nottingham.ac.uk/end_user_agreement.pdf





You might also like



Downloadable Citations